Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 34 articles: HTML format

Single Articles

June 2020
1. ZHAO YC, Tang D, Yang S, Liu H, et al
   Novel variants of ELP2 and PIAS1 in the interferon gamma signaling pathway are associated with non-small cell lung cancer survival.
   Cancer Epidemiol Biomarkers Prev. 2020 Jun 3. pii: 1055-9965.EPI-19-1450.
   PubMed     Abstract available
   
   
   April 2020
2. WANG Y, Gorlova OY, Gorlov IP, Zhu M, et al
   Association analysis of driver-gene related genetic variants identified novel lung cancer susceptibility loci with 20,871 lung cancer cases and 15,971 controls.
   Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1085.
   PubMed     Abstract available
   
   
   
3. PAL CHOUDHURY P, Chaturvedi AK, Chatterjee N
   Evaluating Discrimination of a Lung Cancer Risk Prediction Model Using Partial Risk-score in a Two-phase Study.
   Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1574.
   PubMed     Abstract available
   
   
   
4. WEI Q, Deng W, Liu H, Luo S, et al
   APOB genotypes and CDH13 haplotypes in the cholesterol-related pathway genes predict non-small cell lung cancer survival.
   Cancer Epidemiol Biomarkers Prev. 2020 Apr 1. pii: 1055-9965.EPI-19-1262.
   PubMed     Abstract available
   
   
   December 2019
5. CHIEN LH, Chen CH, Chen TY, Chang GC, et al
   Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model.
   Cancer Epidemiol Biomarkers Prev. 2019 Dec 17. pii: 1055-9965.EPI-19-1221.
   PubMed     Abstract available
   
   
   
6. MUSOLF AM, Moiz BA, Sun H, Pikielny CW, et al
   Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p and 4q.
   Cancer Epidemiol Biomarkers Prev. 2019 Dec 11. pii: 1055-9965.EPI-19-0887.
   PubMed     Abstract available
   
   
   November 2019
7. THOMAS CE, Wang R, Adams-Haduch J, Murphy SE, et al
   Urinary cotinine is as good a biomarker as serum cotinine for cigarette smoking exposure and lung cancer risk prediction.
   Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: 1055-9965.EPI-19-0653.
   PubMed     Abstract available
   
   
   October 2019
8. UDUMYAN R, Montgomery S, Fang F, Valdimarsdottir U, et al
   Beta-blocker use and lung cancer mortality in a nationwide cohort study of patients with primary non-small cell lung cancer.
   Cancer Epidemiol Biomarkers Prev. 2019 Oct 22. pii: 1055-9965.EPI-19-0710.
   PubMed     Abstract available
   
   
   
9. SCHABATH MB, Cote ML
   Cancer Progress and Priorities: Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2019;28:1563-1579.
   PubMed    
   
   
   September 2019
10. D'ANTONA P, Cattoni M, Dominioni L, Poli A, et al
    Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0626.
    PubMed     Abstract available
    
    
    July 2019
11. KACHURI L, Helby J, Bojesen SE, Christiani DC, et al
    Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019;28:1228-1237.
    PubMed     Abstract available
    
    
    April 2019
12. HUO J, Hong YR, Bian J, Guo Y, et al
    Low Rates of Patient-Reported Physician-Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0629.
    PubMed     Abstract available
    
    
    
13. GRAFETSTATTER M, Husing A, Gonzalez Maldonado S, Sookthai D, et al
    Plasma Fibrinogen and sP-Selectin are associated with the risk of lung cancer in a prospective study.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1285.
    PubMed     Abstract available
    
    
    March 2019
14. JONES CC, Bradford Y, Amos CI, Blot WJ, et al
    Cross-cancer pleiotropic associations with lung cancer risk in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 20. pii: 1055-9965.EPI-18-0935.
    PubMed     Abstract available
    
    
    
15. MAGUIRE FB, Morris CR, Parikh-Patel A, Cress RD, et al
    Disparities in systemic treatment use in advanced-stage non-small cell lung cancer by source of health insurance.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0823.
    PubMed     Abstract available
    
    
    February 2019
16. PALAZZO LL, Sheehan DF, Tramontano AC, Kong CY, et al
    Disparities and Trends in Rates of Genetic Testing and Erlotinib Treatment Among Metastatic Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 20. pii: 1055-9965.EPI-18-0917.
    PubMed     Abstract available
    
    
    
17. PETERS BA, Hayes RB, Goparaju C, Reid C, et al
    The microbiome in lung cancer tissue and recurrence-free survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0966.
    PubMed     Abstract available
    
    
    January 2019
18. ZHU Y, Wei Y, Zhang R, Dong X, et al
    Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0356.
    PubMed     Abstract available
    
    
    
19. LUSK CM, Wenzlaff AS, Watza D, Sieren JC, et al
    Quantitative imaging markers of lung function in a smoking population distinguish COPD sub-groups with differential lung cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0886.
    PubMed     Abstract available
    
    
    October 2018
20. NIU Y, Su M, Wu Y, Fu L, et al
    Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0723.
    PubMed     Abstract available
    
    
    
21. BROWN D, Zingone A, Yu Y, Zhu B, et al
    Relationship between circulating inflammation proteins and lung cancer diagnosis in the National Lung Screening Trial.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 8. pii: 1055-9965.EPI-18-0598.
    PubMed     Abstract available
    
    
    September 2018
22. GUO Y, Zhang R, Shen S, Wei Y, et al
    DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 5. pii: 1055-9965.EPI-18-0454.
    PubMed     Abstract available
    
    
    August 2018
23. ERICKSON P, Gardner LD, Loffredo CA, St George DM, et al
    Racial and Ethnic Differences in the Relationship Between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 31. pii: 1055-9965.EPI-18-0366.
    PubMed     Abstract available
    
    
    May 2018
24. DOHERTY JA, Grieshober L, Houck JR, Barnett MJ, et al
    Telomere length and lung cancer mortality among heavy smokers.
    Cancer Epidemiol Biomarkers Prev. 2018 May 9. pii: 1055-9965.EPI-17-1183.
    PubMed     Abstract available
    
    
    March 2018
25. ROSS K, Kramer MR, Jemal A
    Geographic Inequalities in Progress against Lung Cancer among Women in the United States, 1990-2015.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 30. pii: 1055-9965.EPI-17-0934.
    PubMed     Abstract available
    
    
    
26. LIN J, Kamamia C, Brown D, Shao S, et al
    Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER population.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 12. pii: 1055-9965.EPI-17-0822.
    PubMed     Abstract available
    
    
    January 2018
27. ZHAO Y, Varn FS, Cai G, Xiao F, et al
    A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2018;27:86-95.
    PubMed     Abstract available
    
    
    October 2017
28. LUND JL, Sanoff HK, Peacock-Hinton S, Muss H, et al
    Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 4. pii: cebp.0523.2017.
    PubMed     Abstract available
    
    
    July 2017
29. ARGIRION I, Weinstein SJ, Mannisto S, Albanes D, et al
    Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11. pii: cebp.0293.2017.
    PubMed     Abstract available
    
    
    June 2017
30. JONES CC, Bush WS, Crawford DC, Wenzlaff AS, et al
    Germline genetic variants and lung cancer survival in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 15. pii: cebp.0998.2016.
    PubMed     Abstract available
    
    
    
31. BOSSE Y, Amos CI
    A decade of GWAS results in lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 14. pii: cebp.0794.2016.
    PubMed     Abstract available
    
    
    April 2017
32. BOFFA DJ, Graf RP, Salazar MC, Hoag J, et al
    Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.
    Cancer Epidemiol Biomarkers Prev. 2017 Apr 26. pii: cebp.0120.2017.
    PubMed     Abstract available
    
    
    
33. TORRE LA, Islami F, Siegel RL, Ward EM, et al
    Global Cancer in Women: Burden and Trends.
    Cancer Epidemiol Biomarkers Prev. 2017;26:444-457.
    PubMed     Abstract available
    
    
    March 2017
34. BOSSE Y, Sazonova O, Gaudreault N, Bastien N, et al
    Transcriptomic Microenvironment of Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2017;26:389-396.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: